Pharmaceutical Products

Headquarters location:Greenville, North Carolina
Initial investment date:July 1997

Catalytica was a leading provider of bulk actives, chemical intermediates and sterile pharmaceutical products for major pharmaceutical companies, including Merck, Pharmacia & Upjohn, Pfizer and Bristol-Myers Squibb.

In 2000, DSM acquired Catalytica, Inc.'s pharmaceutical business, preceded by a spin-off of Catalytica Combustion Systems and Catalytica Advanced Technologies, now known as Catalytica Energy Systems, Inc. [NASDAQ:CESI]

Contact us  |  Terms of use  |  Privacy
Copyright © 2007 Metalmark Capital Holdings LLC. All rights reserved.
By focusing on core industries, we're able to gain a deeper understanding of a prospective portfolio company’s competitive position.